CHAPTER / APPROVED
What FDA approval does—and does not—tell you
Approval belongs to a specific drug, form, use, and label. It does not spill over to every product with a similar ingredient name.
APPROVED PRODUCT
As of September 2026, FDA has approved the finished medicine and its prescribing information.
SIMILAR NAME
As of September 2026, a separate compounded or online product may use the same ingredient name without sharing that approval.
Check that the approval is for the exact box or pen you would get, not just an ingredient with the same name.
Examples people often mean
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have FDA-approved products as of September 2026.
As of September 2026, other peptide medicines are approved for particular conditions, so “peptide” does not mean “experimental.”
The label is the boundary
The approved label explains the use FDA reviewed, the form, warnings, storage, and other product-specific details.
A general peptide claim cannot replace that product-level information.
Two checks that save time
- Search the generic name (the medicine’s own name, not the brand) in FDA’s approved-drug records.
- Check that the form (such as an injection or a tablet) and brand on the label match the record.
- Treat “FDA registered” and an NDC listing as different from approval.
ENDNOTES / THIS CHAPTER